Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 137 INDUSTRY 75 NIH 15 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Specimen Handling 67 Magnetic Resonance Spectroscopy 52 Cyclophosphamide 45 Vincristine 37 Cisplatin 31 Radiotherapy 30 Radiation 30 Carboplatin 29 Dexamethasone 28 Etoposide 26 Biopsy 26 Doxorubicin 24 daratumumab 18 Prednisone 18 Radiotherapy, Intensity-Modulated 17 durvalumab 16 Platinum 16 Irinotecan 16 Cytarabine 16 Paclitaxel 15 Gemcitabine 15 1,2-diaminocyclohexaneplatinum II citrate 15 Methotrexate 14 Leucovorin 14 Docetaxel 14 Observation 13 Lenalidomide 13 Radiotherapy, Conformal 12 Fluorouracil 12 Calcium Dobesilate 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Azacitidine × 1 year × Clear all

NCT07425808 2026-02-23

FIT-AML

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡